The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
FDA approves ZYFLO CR extended-release tablets for chronic treatment of asthma

Napa, CA (May 31, 2007) Dey, L.P. announced today that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) of its marketing partner, Critical Therapeutics, Inc. (Nasdaq: CRTX), for ZYFLO CR (zileuton) extended-release tablets. ZYFLO CR offers twice-daily, extended-release dosing. Under a co-promotion agreement executed between the two companies in March 2007, DEY will co-market Critical Therapeutics ZYFLO CR.

ZYFLO CR and ZYFLO (zileuton tablets) are the only FDA-approved leukotriene synthesis inhibitors for the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older. ZYFLO CR and ZYFLO are not indicated for use in the reversal of bronchospasm in acute asthma attacks, but can be continued during acute exacerbations of asthma. Leukotrienes are inflammatory mediators in asthma that can trigger asthma symptoms, including inflammation, swelling, bronchoconstriction and mucus secretion. ZYFLO CR uses SkyePharma PLCs (LSE: SKP) proprietary Geomatrix drug delivery technology, which controls the amount and rate of drug released into the body.

We applaud our marketing partners success in securing FDA approval of the only twice-daily leukotriene synthesis inhibitor for asthma, said Mel Engle, President and CEO of DEY. ZYFLO CR has a unique mechanism of action that, combined with its twice-daily dosing regimen, could fundamentally expand and improve the treatment options available to asthma patients. We are delighted to participate in commercializing Critical Therapeutics ZYFLO CR, which will continue to expand DEYs presence in asthma and respiratory care.

In March 2007, Critical Therapeutics and DEY entered into an agreement for the co-promotion of ZYFLO CR and ZYFLO, the immediate-release formulation of zileuton. DEYs sales force began promoting ZYFLO on April 30, 2007. Upon the launch of ZYFLO CR, the combined sales forces of the two companies will begin prom
'"/>

Contact: Harriet Ullman
harriet.ullman@fkhealth.com
617-761-6776
Feinstein Kean Healthcare
31-May-2007


Page: 1 2

Related medicine news :

1. DFG approves 11 new Collaborative Research Centers
2. FDA approves Dey, L.P.s Perforomist inhalation solution for maintenance treatment of COPD
3. VCR -- FDA approves home discharge for US patients
4. FDA approves prescription Zaditor for over-the-counter relief from itchy eyes
5. FDA approves Vectibix to treat patients with metastatic colorectal cancer
6. 5,000 rare diseases need drugs, but Europe only approves a handful each year
7. FDA approves room temperature storage of ZLB Behrings Helixate FS
8. FDA approves new indication for Topamax as initial monotherapy for adults and children with epilepsy
9. FDA approves first blood test to predict risk for stroke
10. FDA approves Boostrix a new US vaccine for adolescents against pertussis
11. Takeda submits new drug application for extended-release type 2 diabetes medication, ACTOplus met

Post Your Comments:
(Date:11/25/2009)....25/PRNewswire-USNewswire/--Whenmostpeoplehearthea...canalsogivepatientsthehelptheyneed.TMJstandsforthe...ble)contacts/connectswithyourskull(temporalbone). ...ctionarepainwithchewing,clickingorpoppingofthejaw....ncluding:headaches,fatigue,sleepdisturbances,irrit...
(Date:11/25/2009)...Nov.25/PRNewswire/--TheBartleHallConventionCenterw...conDec.9-10,whenKansasCityhoststhelatestinaserieso...freecliniceventhasthepotentialtobethebiggestoneyet...beheldonweekdaysinsteadofoveraweekend,"SheriWood,e...presidentoftheNationalAssociationofFreeClinics(NAF...
(Date:11/25/2009)...f.,Nov.25/PRNewswire-FirstCall/-- OnyxPharmaceuti...nywillhosttwoinvestoreventsinDecember: ,, ASH...a.m.ET ,, Principalinvestigatorswilldiscussda.../orrefractorymultiplemyeloma,asfeaturedatthe51stAm...sitioninNewOrleans,LA.Theteleconferencewillbeginat...
(Date:11/25/2009)...RY,Nov.25/PRNewswire/-SentinelleMedicalInc.,aleadi...andsoftwareandCalgaryScientificInc.,aleadingprovid...bversionofAegis(TM)Breast4DAdvancedVisualizationso...lyzero-footprintWebclientbasedmedicalimagingofferi...rmallowsforzero-footprintaccess-requiringnosoftwar...
(Date:11/25/2009)...PRNewswire/-SentinelleMedicalInc.,aleadingmanufact...relaunchesasuiteofnewleadingedgeclinicalapplicatio...isyear,sRadiologicalSocietyofNorthAmerica(RSNA)ann...llA).Theapplicationsleveragetheuniquehighqualityim...ilsandsupportmultipleimagingmodalitiesformulti-par...
Breaking Medicine News(10 mins):Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3
(Date:11/25/2009)...wswire/--PraxisElectronicMedicalRecordsreceivedfir...ans,(AAFP)FamilyPracticeManagement(FPM)2009EHRUser...hmaintenance,anddiseasemanagement,allcriticalforne...ctorsindicatingtheirEMRhadapositiveeffectindetermi...nthecountryinprovidingexcellenttrainingandsupport....
(Date:11/25/2009)...re-FirstCall/--AmericanScientificResourcesInc.(Pin...theyhaveopenedaregionalmarketingandproductionmanag...osecurealocationabroad,providinganessentialgateway...althandsafetyproductsforchildrenandadultstobedistr...entoryinthestateofOhiowheretheywillalsobeabletodos...
(Date:11/25/2009)...ire-FirstCall/--HeskaCorporation(HSKA);("Heska"),a...roductstotheveterinaryindustry,announcedtodayagree...bloodgasproductsandaffiliatedconsumablesforthevete...cgi-bin/prnh/20000622/HESKALOGO ) ,, "HeskaandR...vancedpoint-of-carediagnostics,"commentedMichaelMc...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2American Scientific Resources Inc. Opens Shanghai Location 2Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Brain May Use Its Minds Eye to Control Chaos 55603 1Brain May Use Its Minds Eye to Control Chaos 55603 2VHI Releases Consumer Guide to Obstetrical Services in Virginia 55600 1VHI Releases Consumer Guide to Obstetrical Services in Virginia 55600 2Firearm Owners and Seniors Coalesce Against Obama Agenda Says Gun Law Expert 55597 1Firearm Owners and Seniors Coalesce Against Obama Agenda Says Gun Law Expert 55597 2
Other News:
...ic plague and pneumonic plague being used as biote...d this week in The Lancet.... Professor Mike Prent...Lila Rahalison, of Institut Pasteur, Madagascar, d... the plague, its transmission vectors, and potenti...
...kins may have discovered an unintended benefit in ...r cholesterol: The medications, all statins, seem ...fection known as sepsis in patients on kidney dial... of the Journal of the American Medical Associatio...
...ther to child can occur in utero, during labor or ...ly 25 percent of newborns exposed to the virus fro...selves and potentially develop AIDS. Fortunately, ...include AZT (zidovudine), a nucleoside reverse tra...
...lts being overweight and 23% being obese, plus the...lear that obesity is a major individual and public...f the Obesity Canada Clinical Practice Guidelines ...e University of Calgary, provides a synopsis of th...
health news:The plague as a weapon? 2health news:Statins linked to lower risk of infection 2health news:Drug used to prevent HIV transmission from mother to child damages DNA 2health news:Drug used to prevent HIV transmission from mother to child damages DNA 3
... growth factor genes into the heart appears safe a...st pain known as angina, according to a report in ...of the American Heart Association.... The Angiogen...-controlled, double-blind trial of the therapy in ...
...tudy in new treatment area presented...at the Amer... 15th annual meeting ...... Orlando, Florid...nepezil hydrochloride tablets) significantly impro... patients with vascular dementia (VaD), compared w...
...t allowing employees to work alone at night and pr...en after dark can reduce workplace homicides, uniq...arolina at Chapel Hill shows.......Other individua...d warning signs or increasing visibility of the wo...
...Childrens Hospital and Adelaide University, Depart...hat acupuncture is an extremely effective treatmen...ge trial was undertaken involving 593 women who we...usea or vomiting. Twenty-minute sessions of acupun...
health news:Gene therapy to treat angina appears safe 2health news:Gene therapy to treat angina appears safe 3health news:First-of-its-kind study of vascular dementia patients taking ARICEPT presented at AAGP meeting 2health news:First-of-its-kind study of vascular dementia patients taking ARICEPT presented at AAGP meeting 3health news:First-of-its-kind study of vascular dementia patients taking ARICEPT presented at AAGP meeting 4health news:Not working alone at night, outside lights can cut workplace homicides, study shows 2